Comprehensive medication guide to Protopic including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$60 copay for generic tacrolimus ointment on most commercial plans; typically Tier 2–3 with prior authorization required. Brand Protopic rarely covered — step therapy through generic is standard.
Estimated Cash Pricing
$59–$300 retail for generic tacrolimus ointment (30g); as low as $40–$53 with GoodRx or SingleCare coupons for a 60g tube. Brand-name Protopic costs $275–$300 per 30g tube at retail.
Medfinder Findability Score
75/100
Summarize with AI
On this page
Protopic is the brand name for tacrolimus ointment, a prescription topical medication used to treat moderate to severe atopic dermatitis (eczema). It belongs to a drug class called topical calcineurin inhibitors (TCIs) — a family of non-steroid medications that work by calming the overactive immune response responsible for eczema flares.
Protopic is available in two strengths: 0.03% (approved for ages 2 and older, and preferred for sensitive areas) and 0.1% (approved for adults and teenagers 16 and older). It is classified as a second-line treatment, meaning it is typically prescribed after topical corticosteroids have not provided adequate control or are not tolerated.
Generic tacrolimus ointment (bioequivalent to Protopic) is manufactured by companies including Padagis and others, and is available at a fraction of the brand-name cost.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Protopic (tacrolimus) works by blocking a key enzyme called calcineurin inside T-lymphocytes (T-cells) in the skin. When tacrolimus penetrates the skin, it binds to an intracellular protein called FKBP-12. The resulting tacrolimus-FKBP-12 complex inhibits calcineurin, which prevents a transcription factor called NFAT (Nuclear Factor of Activated T-cells) from entering the cell nucleus.
Without NFAT activity, the genes for inflammatory cytokines — including interleukin-2 (IL-2), IL-4, IL-5, IL-13, and tumor necrosis factor-alpha — are not expressed. The result is a localized reduction in skin inflammation, relieving the itch, redness, swelling, and skin damage that characterize eczema flares.
Unlike topical corticosteroids, tacrolimus does not work through glucocorticoid receptors and does not affect collagen-producing fibroblasts. This means Protopic does not cause skin thinning (atrophy), making it especially valuable for long-term management of eczema on the face, eyelids, neck, and skin folds — areas where steroid use is limited.
0.03% — ointment
For children ages 2–15 and for sensitive areas in adults. Apply twice daily to affected skin.
0.1% — ointment
For adults and teenagers 16 and older with moderate to severe eczema. Apply twice daily to affected skin.
Protopic has a findability score of 75 out of 100, meaning it is generally available but some patients encounter localized stockouts. As of 2026, Protopic is not listed on the FDA's active drug shortage database. However, individual pharmacies — particularly chain locations — may periodically run out of one or both strengths (0.03% and 0.1%), especially during peak eczema season in the fall and winter months.
Generic tacrolimus ointment is more widely distributed than brand-name Protopic and is manufactured by multiple companies. Patients who request generic tacrolimus ointment (instead of specifically asking for Protopic) will generally have an easier time finding it. Larger pharmacies, specialty pharmacies, and mail-order services tend to stock it more reliably.
If your pharmacy is out of Protopic, medfinder can help. medfinder calls pharmacies near you to find which ones have your medication in stock, so you don't have to spend hours on the phone. Results are sent directly to your phone by text.
Protopic (tacrolimus ointment) is not a controlled substance, so it can be prescribed by any licensed prescriber in the United States without DEA special registration. However, because Protopic is a second-line therapy requiring documented failure of topical steroids, prescribers familiar with atopic dermatitis management are best positioned to handle prior authorization requirements.
Dermatologists (most common prescribers; specialists in atopic dermatitis)
Allergists and immunologists (especially for atopic triad patients)
Pediatricians (for children ages 2+ with eczema; may refer to pediatric dermatology for severe cases)
Primary care physicians (PCPs) and family medicine physicians
Nurse practitioners (NPs) and physician assistants (PAs) — prescribing authority in most states
Telehealth access: Protopic is available via telehealth platforms in 2026. Since it is non-controlled, licensed online prescribers can evaluate patients via video or photo consultation and send the prescription to a local pharmacy. This is useful for patients with limited specialist access or long wait times. Platforms including Teladoc, Curology, and DermatologistOnCall offer dermatology services that can prescribe tacrolimus ointment.
No. Protopic (tacrolimus ointment) is not a DEA-controlled substance. It is not scheduled under the Controlled Substances Act, and it has no known potential for abuse or dependence. This means:
Prescriptions can be written for refills (no limit on refills beyond what the prescriber specifies)
Prescriptions can be called in or faxed to the pharmacy — no physical prescription required by law
Telehealth providers can legally prescribe Protopic across state lines in most circumstances
No special DEA registration is required to prescribe it
The FDA does require that prescribers provide patients with a Medication Guide at each fill, due to the boxed warning about potential cancer risk. However, this is not the same as controlled substance requirements.
The most common side effects occur at the skin application site and are most pronounced during the first few days of treatment:
Stinging or burning sensation at the application site (occurs in up to 50–70% of patients)
Itching at the application site
Skin redness or warmth at the treated area
Alcohol flush reaction (flushing, redness, and warmth when drinking alcohol while medication is on skin — occurs in ~15–20% of users)
Increased sun sensitivity
Boxed Warning — Possible cancer risk: A small number of patients using Protopic have developed skin cancer or lymphoma. A causal link has not been established, but the FDA requires this warning. Use only on affected areas, do not use continuously for long periods, and stop when eczema resolves.
Increased infection risk: Protopic lowers the skin's local immune response, increasing susceptibility to viral infections (herpes, chickenpox, shingles). Do not apply to infected skin.
Severe allergic reaction (rare): Contact urticaria and rare anaphylaxis-like reactions have been reported. Seek emergency care if you develop hives, swelling, or difficulty breathing.
Know what you need? Skip the search.
Elidel (Pimecrolimus Cream)
Another topical calcineurin inhibitor in the same drug class as Protopic. Best for mild to moderate eczema in ages 2+. Available as generic pimecrolimus cream at significantly lower cost ($50–$150 with coupon).
Eucrisa (Crisaborole Ointment)
A PDE4 inhibitor approved for mild to moderate eczema in ages 3 months and older. No generic available; costs $700–$900/tube without insurance. Does not carry the same boxed warning as Protopic.
Dupixent (Dupilumab)
A biologic injection (IL-4/IL-13 inhibitor) approved for moderate to severe eczema in ages 6 months+. Significantly more effective than topical treatments for severe disease. Costs $30,000–$40,000/year at list price; copay assistance available.
Topical Corticosteroids
First-line standard of care for eczema. Widely available and inexpensive. Not recommended for long-term use on the face, eyelids, or skin folds due to skin thinning risk — which is why Protopic is preferred for these areas.
Prefer Protopic? We can find it.
Ketoconazole / Itraconazole / Voriconazole (Antifungals)
moderateCYP3A4 inhibitors that can increase systemic tacrolimus levels in patients with widespread disease. Use with caution; inform prescriber.
Clarithromycin / Erythromycin (Macrolide Antibiotics)
moderateCYP3A4 inhibitors; may increase tacrolimus blood levels if significant systemic absorption occurs. Most clinically relevant in patients with severe, widespread eczema.
Alcohol
minorConcurrent use can trigger an alcohol flush reaction — sudden redness, heat, and burning at treated skin sites — in approximately 15–20% of users. Temporary and not dangerous.
Cimetidine (Tagamet)
minorOver-the-counter heartburn medication; mild CYP3A4 inhibitor. Unlikely to be clinically significant for most topical users but worth mentioning to pharmacist.
Immunosuppressive Drugs (cyclosporine, methotrexate, biologics)
moderateAdditive immunosuppression when used with other systemic immunosuppressants. Combinations are not necessarily contraindicated but require monitoring and prescriber supervision.
Protopic (tacrolimus ointment) has been an important option for patients with moderate to severe atopic dermatitis since its FDA approval, particularly for those who need treatment on sensitive skin areas where long-term steroid use is problematic. Its mechanism — calcineurin inhibition without the skin-thinning risks of corticosteroids — makes it uniquely suitable for facial, periorbital, and skin-fold eczema.
In 2026, Protopic and generic tacrolimus ointment are not in a formal shortage. Availability is generally good, though localized pharmacy stockouts occur. The most practical strategies for patients: request generic tacrolimus ointment (not brand-only), use a GoodRx coupon to dramatically cut costs, refill early before running out, and use medfinder if your local pharmacy is out of stock.
If you're struggling to find Protopic in stock, medfinder calls pharmacies near you to check which ones have it — saving you hours of calling around yourself. Provide your medication, dosage, and ZIP code, and receive the results by text.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards